Form 8-K - Current report:
SEC Accession No. 0001193125-25-003519
Filing Date
2025-01-08
Accepted
2025-01-08 16:16:05
Documents
15
Period of Report
2025-01-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d894323d8k.htm   iXBRL 8-K 29408
2 EX-99.1 d894323dex991.htm EX-99.1 35458
6 GRAPHIC g894323g0108084901063.jpg GRAPHIC 2466
  Complete submission text file 0001193125-25-003519.txt   201387

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zyme-20250108.xsd EX-101.SCH 2855
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20250108_lab.xml EX-101.LAB 17993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20250108_pre.xml EX-101.PRE 11264
17 EXTRACTED XBRL INSTANCE DOCUMENT d894323d8k_htm.xml XML 3629
Mailing Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709
Business Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709 302-274-8744
Zymeworks Inc. (Filer) CIK: 0001937653 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41535 | Film No.: 25518723
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)